Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide.

German medical science : GMS e-journal

Volumn 7, Issue , 2009, Pages

  Kraemer, Anja ^a   Hauser, Stefan ^a   Kim, Young ^a   Gorschlüter, Marcus ^a   Müller, Stefan C ^a   Brossart, Peter ^a   Schmidt Wolf, Ingo G H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; IMMUNOSUPPRESSIVE AGENT; PRODRUG; THALIDOMIDE;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; GERMANY; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, RENAL CELL; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; FLUOROURACIL; GERMANY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRODRUGS; SURVIVAL RATE; THALIDOMIDE; TREATMENT OUTCOME;

EID: 73349121657     PISSN: None     EISSN: 16123174     Source Type: Journal    
DOI: None     Document Type: Article

References (0)